Effect of Fistula Training in Hemodialysis Patients

April 26, 2024 updated by: Özlem Özdemir, Kırklareli University

The Effect of Fistula Education Given to Patients Receiving Hemodialysis Treatment on Self-Care Behaviors

It was planned to examine the effect of fistula-related education given to patients receiving hemodialysis treatment on their self-care behaviors.

Nurse-led education about fistula for hemodialysis patients affects fistula self-care behaviors.

Nurse-led training regarding fistula to hemodialysis patients does not affect fistula self-care behaviors.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Hemodialysis patients in the experimental group will be given face-to-face training in 2 sessions. Patients will also receive an educational brochure on fistula self-care. Simultaneously, patients will receive routine treatment and care.

No intervention will be performed on patients in the control group. These patients will receive normal treatment and care.

A pre-test will be applied to both groups at the first meeting and their self-care behaviors related to fistula will be examined. Three months later, fistula-related self-care behaviors will be evaluated again with the relevant scale.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years and over,with chronic kidney disease
  • Having a fistula as a vascular access route
  • Receiving hemodialysis treatment for at least 6 months

Exclusion Criteria:

  • Those with acute renal failure,
  • Having a graft and catheter as a vascular access route,
  • Not volunteering to participate in the research
  • Those with communication problems (hearing, language, understanding, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
routine care
Experimental: Education
The patient receiving hemodialysis treatment will be given fistula self-care training in 2 sessions. An educational booklet will be provided after the training.
The patient receiving hemodialysis treatment will be given fistula self-care training in 2 sessions. An educational booklet will be provided after the training.And routine care
Other Names:
  • experimental

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Information Form
Time Frame: 1-3 month
Contains disease-related and sociodemographic information
1-3 month
Self-Care Behavior Assessment Scale Regarding Arteriovenous Fistula in Hemodialysis Patients
Time Frame: 1-3 month
he scale was adapted from Sousa et al. Developed by. Turkish validity and reliability, İkiz et al. It was done by. The scale consists of the subscales "management of symptoms and signs" and "prevention of complications". An increase in the score indicates that the person's self-care behaviors regarding fistula care are improving
1-3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 26, 2024

Primary Completion (Estimated)

August 30, 2024

Study Completion (Estimated)

September 15, 2024

Study Registration Dates

First Submitted

April 24, 2024

First Submitted That Met QC Criteria

April 26, 2024

First Posted (Actual)

April 30, 2024

Study Record Updates

Last Update Posted (Actual)

April 30, 2024

Last Update Submitted That Met QC Criteria

April 26, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Kirklareli Ozlem Ozdemir

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe